Cargando…

Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform

Genome engineering technologies are powerful tools in cell-based immunotherapy to optimize or fine-tune cell functionalities. However, their use for multiple gene edits poses relevant biological and technical challenges. Short hairpin RNA (shRNA)-based cell engineering bypasses these criticalities a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Matteo, Steklov, Mikhail, Huberty, Fanny, Nguyen, Thuy, Marijsse, Jérôme, Jacques-Hespel, Céline, Najm, Paul, Lonez, Caroline, Breman, Eytan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548280/
https://www.ncbi.nlm.nih.gov/pubmed/37799328
http://dx.doi.org/10.1016/j.omtn.2023.102038
_version_ 1785115241603923968
author Rossi, Matteo
Steklov, Mikhail
Huberty, Fanny
Nguyen, Thuy
Marijsse, Jérôme
Jacques-Hespel, Céline
Najm, Paul
Lonez, Caroline
Breman, Eytan
author_facet Rossi, Matteo
Steklov, Mikhail
Huberty, Fanny
Nguyen, Thuy
Marijsse, Jérôme
Jacques-Hespel, Céline
Najm, Paul
Lonez, Caroline
Breman, Eytan
author_sort Rossi, Matteo
collection PubMed
description Genome engineering technologies are powerful tools in cell-based immunotherapy to optimize or fine-tune cell functionalities. However, their use for multiple gene edits poses relevant biological and technical challenges. Short hairpin RNA (shRNA)-based cell engineering bypasses these criticalities and represents a valid alternative to CRISPR-based gene editing. Here, we describe a microRNA (miRNA)-based multiplex shRNA platform obtained by combining highly efficient miRNA scaffolds into a chimeric cluster, to deliver up to four shRNA-like sequences. Thanks to its limited size, our cassette could be deployed in a one-step process along with all the CAR components, streamlining the generation of engineered CAR T cells. The plug-and-play design of the shRNA platform allowed us to swap each shRNA-derived guide sequence without affecting the system performance. Appropriately choosing the target sequences, we were able to either achieve a functional KO, or fine-tune the expression levels of the target genes, all without the need for gene editing. Through our strategy we achieved easy, safe, efficient, and tunable modulation of multiple target genes simultaneously. This approach allows for the effective introduction of multiple functionally relevant tweaks in the transcriptome of the engineered cells, which may lead to increased performance in challenging environments, e.g., solid tumors.
format Online
Article
Text
id pubmed-10548280
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-105482802023-10-05 Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform Rossi, Matteo Steklov, Mikhail Huberty, Fanny Nguyen, Thuy Marijsse, Jérôme Jacques-Hespel, Céline Najm, Paul Lonez, Caroline Breman, Eytan Mol Ther Nucleic Acids Original Article Genome engineering technologies are powerful tools in cell-based immunotherapy to optimize or fine-tune cell functionalities. However, their use for multiple gene edits poses relevant biological and technical challenges. Short hairpin RNA (shRNA)-based cell engineering bypasses these criticalities and represents a valid alternative to CRISPR-based gene editing. Here, we describe a microRNA (miRNA)-based multiplex shRNA platform obtained by combining highly efficient miRNA scaffolds into a chimeric cluster, to deliver up to four shRNA-like sequences. Thanks to its limited size, our cassette could be deployed in a one-step process along with all the CAR components, streamlining the generation of engineered CAR T cells. The plug-and-play design of the shRNA platform allowed us to swap each shRNA-derived guide sequence without affecting the system performance. Appropriately choosing the target sequences, we were able to either achieve a functional KO, or fine-tune the expression levels of the target genes, all without the need for gene editing. Through our strategy we achieved easy, safe, efficient, and tunable modulation of multiple target genes simultaneously. This approach allows for the effective introduction of multiple functionally relevant tweaks in the transcriptome of the engineered cells, which may lead to increased performance in challenging environments, e.g., solid tumors. American Society of Gene & Cell Therapy 2023-09-20 /pmc/articles/PMC10548280/ /pubmed/37799328 http://dx.doi.org/10.1016/j.omtn.2023.102038 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Rossi, Matteo
Steklov, Mikhail
Huberty, Fanny
Nguyen, Thuy
Marijsse, Jérôme
Jacques-Hespel, Céline
Najm, Paul
Lonez, Caroline
Breman, Eytan
Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title_full Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title_fullStr Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title_full_unstemmed Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title_short Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform
title_sort efficient shrna-based knockdown of multiple target genes for cell therapy using a chimeric mirna cluster platform
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548280/
https://www.ncbi.nlm.nih.gov/pubmed/37799328
http://dx.doi.org/10.1016/j.omtn.2023.102038
work_keys_str_mv AT rossimatteo efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT steklovmikhail efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT hubertyfanny efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT nguyenthuy efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT marijssejerome efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT jacqueshespelceline efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT najmpaul efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT lonezcaroline efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform
AT bremaneytan efficientshrnabasedknockdownofmultipletargetgenesforcelltherapyusingachimericmirnaclusterplatform